Kanglin Wang

Title: Innovations of Kanglin Wang in Genetic Engineering

Introduction

Kanglin Wang is a notable inventor based in Anhui, China. He has made significant contributions to the field of genetic engineering, particularly in the development of genetically engineered bacteria. His work focuses on enhancing the production of nicotinamide adenine dinucleotide (NAD), a crucial coenzyme in cellular metabolism.

Latest Patents

Kanglin Wang holds a patent for a genetically engineered bacterium, its construction method, and its application in producing NAD. The invention discloses a genetically engineered bacterium in which the gene encoding adenine deaminase on the genome of the bacterium is knocked out or/and the gene encoding the enzyme in the NAD anabolic pathway is integrated into the genome of the bacterium. This innovative approach allows for the creation of a strain with high NAD yield, significantly improving the efficiency of NAD production.

Career Highlights

Kanglin Wang is associated with Hefei Knature Bio-pharm Co., Ltd., where he continues to advance his research in biotechnology. His work has garnered attention for its potential applications in various industries, including pharmaceuticals and bioengineering.

Collaborations

Kanglin Wang collaborates with talented individuals such as Wei Wang and Minjie Fu, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Kanglin Wang's contributions to genetic engineering, particularly through his patented work on genetically engineered bacteria, highlight his role as a leading inventor in the field. His innovative methods for producing NAD have the potential to impact various sectors significantly.